Stichting Hemato-Oncologie voor Volwassenen Nederland clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

1. Notable

   HO171 · Cobicistat Boosted Venetoclax in Combination With…HO171 · Cobicistat Boosted Venetoclax in Combination With Azacitidine · Newly Diagnosed AML

   Primary and study completion pushed from Mar 2028 to Dec 2028

   Stichting Hemato-Oncologie voor Volwassenen Nederland·Phase 2· NCT06014489· Registry history of NCT06014489 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.